Thomas C. Skalak
Contact Us
P.O. Box 400301
Charlottesville, VA 22904
- Phone:
- 434-924-3606
- Fax:
- 434-924-3667
- Email:
- vpresearch@virginia.edu
Quick Links
- U.Va. Venture Summit
- Medical Devices Technology Innovation Partnership (MD-TIP) Workshop
- U.Va.'s First Executive Director of Innovation Partnerships
- National Research Council (NRC) Assessment
- NSF Partnerships for Innovation Grantees' Workshop
- Virginia-Research, Innovation, Science, Engineering (V-RISE)
- Federal Economic Stimulus Information
- U.Va. Bay Game
- Virginia Innovation Partnership
- Sign up for our monthly research e-newsletter
The Office of the Vice President for Research (VPR) manages five principal activities:
- Research Compliance
- Research Enhancement
- Intellectual Property Management
- Graduate Studies
- Postdoctoral Enhancement
In addition, the directors of five interdisciplinary research institutes and programs report to the VPR:
- Morphogenesis and Regenerative Medicine
- Nano and Quantum Science and Engineering
- Programs in Computer and Information Science and Engineering
- Healthy Aging
- Environment, Conservation, and Culture
VPR also coordinates the various University units that comprise the research infrastructure, including the acquisition of research funding, the planning and development of academic research space, research commercialization, the incubation of new companies and recruiting of corporate research partners to local research parks, and public outreach.
Events
News
The Presidential Poster Competition for 2012 has been announced! This year's theme: IMPACT.
An important message from Thomas C. Skalak, to Principal Investigators and Researchers occupying UVa laboratory space. (NEW!)
Registration is now open for the 4th Annual UVa Venture Summit on April 19-20, 2012!
Mark Crowell, UVa's Associate Vice President of Research and Executive Director of Innovation Partnerships & Commercialization, attends President Obama's signing of the America Invents Act. See the Daily Progress and UVA Today stories.
On September 26, 2011, the University of Virginia will co-sponsor a U.S. Food & Drug Administration (FDA) workshop on medical device innovation, regulation, device education and translational research. (Information regarding the Bioresearch Monitoring program can be found here and here. Presentation regarding sponsor responsibilties can be found here. Presentation regarding investigator responsibilities can be found here.)
Mark Crowell, UVa's Executive VP for Innovation Partnerships and Commercialization, provides his insight and vision for the growth of biotechnology in Charlottesille. Read the Daily Progress story.
UVa and the Wallace H. Coulter Foundation have teamed together to create a $20 million endowment for translational research in biomedical innovation. This partnership will foster research collaboration between biomedical engineers and clinicians, resulting in new technologies to improve patient care and human health.
Three of the UVa's most accomplished faculty researchers – physicist Thomas F. Gallagher, pharmacologist Patrice G. Guyenet and microbiologist Kodi S. Ravichandran – have been selected to receive the University's 2011 Distinguished Scientist Awards.
UVa's Biomedical Innovation Fund has awarded $265,000 to six biomedical research projects that will advance health care and create economic growth.
UVa's 3rd Annual Venture Summit was held on March 3-4, 2011. Read about how entrepreneurs and investors are linking together at UVa to "Change the World". The Venture Summit also included a pitch session, featuring companies based on UVa research or with alumni connections.
Read about Tom Skalak's vision for UVa's research enterprise.